	PEOPLE	CENTERS	COMMUNITIES	RESEARCH STORIES

USE OF NANOSTING ADJUVANT VACCINE FOR TUBERCULOSIS

USE OF NANOSTING ADJUVANT VACCINE FOR TUBERCULOSIS

PI: Hugues Ouellet

Sponsor: UNIVERSITY OF HOUSTON

Biological Sciences

Amount awarded: $12,000

In collaboration with the University of Houston, this research tests an experimental vaccine to protect against the infectious Mycobacteriun tuberculosis bacilli.

Posting date: Tue, 10/04/2022

Award start date: Thu, 09/01/2022

Award end date: Thu, 08/31/2023

Some of the content on this web site includes information taken from UTEP's Faculty Success (formerly Digital Measures) and Marketing and Communications.
This material is based upon work supported in part by the Research & Innovation and the National Science Foundation under Grant No. DUE-0963648 and CREST Grant No. HRD-1242122. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation (NSF).